GLRA
Gerald L. Ray & Associates’s Bristol-Myers Squibb BMY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | $11.1M | Buy |
174,805
+3,150
| +2% | +$201K | 1.39% | 11 |
|
|
2017
Q2 | $9.56M | Buy |
171,655
+2,530
| +1% | +$141K | 1.23% | 15 |
|
|
2017
Q1 | $9.2M | Buy |
169,125
+8,340
| +5% | +$454K | 1.26% | 17 |
|
|
2016
Q4 | $9.4M | Buy |
160,785
+2,140
| +1% | +$125K | 1.36% | 15 |
|
|
2016
Q3 | $8.55M | Buy |
158,645
+26,930
| +20% | +$1.45M | 1.28% | 16 |
|
|
2016
Q2 | $9.69M | Sell |
131,715
-533
| -0.4% | -$39.2K | 1.55% | 13 |
|
|
2016
Q1 | $8.45M | Buy |
132,248
+665
| +0.5% | +$42.5K | 1.37% | 16 |
|
|
2015
Q4 | $9.05M | Sell |
131,583
-850
| -0.6% | -$58.5K | 1.43% | 14 |
|
|
2015
Q3 | $7.84M | Sell |
132,433
-350
| -0.3% | -$20.7K | 1.31% | 15 |
|
|
2015
Q2 | $8.84M | Buy |
132,783
+1,748
| +1% | +$116K | 1.34% | 14 |
|
|
2015
Q1 | $8.45M | Sell |
131,035
-430
| -0.3% | -$27.7K | 1.27% | 15 |
|
|
2014
Q4 | $7.76M | Sell |
131,465
-250
| -0.2% | -$14.8K | 1.19% | 18 |
|
|
2014
Q3 | $6.74M | Buy |
131,715
+130
| +0.1% | +$6.65K | 1.1% | 26 |
|
|
2014
Q2 | $6.38M | Buy |
131,585
+500
| +0.4% | +$24.3K | 1.09% | 25 |
|
|
2014
Q1 | $6.81M | Sell |
131,085
-600
| -0.5% | -$31.2K | 1.23% | 20 |
|
|
2013
Q4 | $7M | Buy |
131,685
+554
| +0.4% | +$29.4K | 1.32% | 19 |
|
|
2013
Q3 | $6.07M | Sell |
131,131
-500
| -0.4% | -$23.1K | 1.26% | 20 |
|
|
2013
Q2 | $5.88M | Buy |
+131,631
| New | +$5.88M | 1.32% | 20 |
|